Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Nicole Perera"'
2
Patients with Advanced Non-Small Cell Lung Cancer: Are Research Biopsies a Barrier to Participation in Clinical Trials?
Autor: Mike Sung, Nazanin Nouriany, Nicole Perera-Low, M. Sawczak, Andrea Foster, Ronald Feld, Geoffrey Liu, Dianne Zawisza, Tuhina Paul, Frances A. Shepherd, Charles Henry Lim, Natasha B. Leighl
Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 11(1)
ObjectivesClinical trials of therapies for non–small cell lung cancer (NSCLC) are increasingly requiring mandatory tumor samples or research biopsies, both of which are potential barriers to trial participation. We assessed the impact of performanc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a8d8ea7b9ddba495e2012e0a704a936
https://pubmed.ncbi.nlm.nih.gov/26762742
Zobrazit plný text záznamu
4
Patients’ willingness to pay for blood-based EGFR T790M testing: Results from a Canadian validation study of circulating DNA T790M testing
Autor: Leslie Markin, Tristan A. Barnes, Geoffrey Liu, Linda Wong, David Laurence, Ilda Carvalhana, Natasha B. Leighl, Ronald Burkes, S. Owen, Ming-Sound Tsao, Mussawar Iqbal, Jeffrey Rothenstein, Janessa Laskin, M. Sawczak, Nicole Perera-Low, Parneet K. Cheema
Publikováno v: Journal of Clinical Oncology. 35:e18329-e18329
e18329 Background: Detection of EGFRmutations in circulating tumor DNA (ctDNA) in peripheral blood has been shown to have high concordance with definitive tumor biopsy samples. Patients’ perceived value and willingness to pay for novel technology c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cbd83ef62617d23f2bea485f9743ae79
https://doi.org/10.1200/jco.2017.35.15_suppl.e18329
Zobrazit plný text záznamu
5
A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC)
Autor: Wei Xu, Geoffrey Liu, Ronald Feld, Abul Kalam Azad, Nicole Perera, Qin Kuang, Zhuo Chen, Xin Qiu, Sinead Cuffe, Ming-Sound Tsao, Marjan Emami, Dangxiao Cheng, Prakruthi R. Palepu, Devalben Patel, Frances A. Shepherd, Kevin Boyd, Natasha B. Leighl
Publikováno v: Lung cancer (Amsterdam, Netherlands). 84(3)
Lung cancer is a leading cause of cancer-related mortality in North America. In addition to tobacco smoking, inherited genetic factors can also influence the development of lung cancer. These genetic factors may lead to biologically distinct subsets
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7d4600adcf290fd847f6c13eeb556a9
https://pubmed.ncbi.nlm.nih.gov/24679952
Zobrazit plný text záznamu
6
Impact and feasibility of a comprehensive geriatric assessment in the oncology setting: a pilot study
Autor: Jennifer J. Knox, Marjan Emami, Geoffrey Liu, Shabbir M.H. Alibhai, Linda E. Coate, Nicole Perera, Natasha B. Leighl, Prakruthi R. Palepu, Anne M. Horgan
Publikováno v: American journal of clinical oncology. 35(4)
A comprehensive geriatric assessment (CGA) is an objective means of assessing the global health of older patients. While evidence suggesting its promise in improving outcome prediction in the oncology setting is growing, its benefit in guiding treatm
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df00a8c030a32bc82c1cde3fbd70fb15
https://pubmed.ncbi.nlm.nih.gov/21422992
Zobrazit plný text záznamu
7
Patients with advanced non-small cell lung cancer (NSCLC): Are research biopsies a barrier to participation in clinical trials?
Autor: Natasha B. Leighl, Frances A. Shepherd, Geoffrey Liu, Ronald Feld, M. Sawczak, Nicole Perera-Low, Tuhina Paul, Nazanin Ziapour Nouriany, Mike Sung, Charles Henry Lim
Publikováno v: Journal of Clinical Oncology. 33:6534-6534
6534 Background: The evolution of targeted therapy in NSCLC has led to growing complexity of clinical research and a heightened expectation of clinical benefit for participants. Clinical trials in ...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6b7590827c3b611b1ba63994029ca411
https://doi.org/10.1200/jco.2015.33.15_suppl.6534
Zobrazit plný text záznamu
9
Genetic sequence variant (GSV) in TERT-CLPTM1L (5p15.33 locus) and survival in platinum-treated stage-IV non-small cell lung cancer (NSCLC)
Autor: Marjan Emami, Geoffrey Liu, Zhuo Chen, Devalben Patel, Frances A. Shepherd, Kevin Boyd, Ronald Feld, Ming-Sound Tsao, Nicole Perera, Abul Kalam Azad, Qin Kuang, Sinead Cuffe, Xin Qiu, Natasha B. Leighl, Dangxiao Cheng, Prakruthi R. Palepu, Xiaoping Qiu, Wei Xu
Publikováno v: Journal of Clinical Oncology. 30:1535-1535
1535 Background: Lung cancer is a leading cause of cancer-related mortality in North America. Besides tobacco smoking, inherited genetic factors can also influence the development of lung cancer. These genetic factors may lead to biologically distinc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::79c2022b985cbb482ad1d07c16c173e9
https://doi.org/10.1200/jco.2012.30.15_suppl.1535
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje